This inventor holds 1 USPTO granted patent. Top assignees: National Institute of Infectious Diseases, National University Corporation Kumamoto University, Tokyo Medical and Dental University. Active years: 2025.
Company Filing History:
1 out of 37 
1 out of 9 
1 out of 134 
Years Active: 2025
Title: Ami Masuda: Innovator in Anti-HIV Compounds
Introduction
Ami Masuda is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at combating HIV. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to improving healthcare.
Latest Patents
Masuda holds a patent for a CD4 mimic compound with anti-HIV activity. This patent describes CD4 mimic compounds that exhibit improved efficacy for anti-HIV treatment and enhanced pharmacokinetics. The compounds are represented by a specific formula, wherein Ris can be CH(OCH)—OCH or CH, Ris can be O or NH, with n ranging from 3 to 25, and m from 4 to 22, or a salt thereof. Additionally, the patent discloses HIV infection inhibitor compositions that include the compound or a salt thereof as an active ingredient.
Career Highlights
Throughout her career, Ami Masuda has worked with esteemed institutions such as the National University Corporation Kumamoto University and Tokyo Medical and Dental University. Her work in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
Masuda has collaborated with notable colleagues, including Shuzo Matsushita and Kazuhisa Yoshimura. These partnerships have further enriched her research and innovation in the field of anti-HIV compounds.
Conclusion
Ami Masuda's contributions to the development of anti-HIV compounds highlight her role as a leading inventor in the field of medicinal chemistry. Her innovative work continues to pave the way for advancements in HIV treatment and demonstrates her commitment to improving public health.